IL-8 from CD248-expressing cancer-associated fibroblasts generates cisplatin resistance in non-small cell lung cancer
This report highlights a potential new approach to enhancing the chemotherapeutic potential of NSCLC-treating cisplatin.PMID:38396325 | PMC:PMC10891307 | DOI:10.1111/jcmm.18185
Source: J Cell Mol Med - Category: Molecular Biology Authors: Jieheng Wu Qiaoling Zhang Jiangwei Wu Zeyang Yang Xinlei Liu Chunju Lou Xuanyin Wang Jiangying Peng Jinyuan Zhang Zhenling Shang Jing Xiao Nianxue Wang Ruya Zhang Jinyao Zhou Yun Wang Zuquan Hu Rui Zhang Jian Zhang Zhu Zeng Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Lung Cancer | Molecular Biology | Non-Small Cell Lung Cancer | Study